Apac
  • Home
  • CXO Insights
  • CIO Views
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • About us
Apac
  • Admired Tech

    Agile

    AI Healthcare

    Artificial Intelligence

    Augmented Reality

    Aviation

    Big Data

    Blockchain

    Cloud

    Cryptocurrency

    Cyber Security

    Digital Transformation

    Drone

    HPC

    Infrared

    Internet of Things

    Networking

    PropTech

    Remote Work

    Scheduling Software

    Simulation

    Startup

    Storage

    Wireless

  • Banking

    E-Commerce

    Education

    FinTech

    Food and Beverages

    Healthcare

    Insurance

    Legal

    Manufacturing

    Pharma and Life Science

    Retail

    Travel and Hospitality

  • CISCO

    Microsoft

    Oracle

    Salesforce

    SAP

    ServiceNow

  • Business Intelligence

    CEM

    Cloud-based Planning

    Cognitive

    Compliance

    Contact Center

    Contact Tracing

    Contactless Payments

    Corporate Finance

    CRM

    Custom Software Development

    Data Center

    Enterprise Architecture

    Enterprise Communications

    Enterprise Contract Management

    Field Service

    HR Technology

    IT Service Management

    Managed Services

    Procurement

    Product Management

    RegTech

    Revenue Management

Menu
    • CISCO
    • Collaboration
    • Compliance
    • Contact Center
    • Healthcare
    • IT Service Management
    • Microsoft
    • Retail
    • MORE
    #

    Apac CIO Outlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIO Outlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    • Home
    • News
    • Healthcare
    Editor's Pick (1 - 4 of 8)
    left
    Technology’s Role in The Care and Quality of Life for The Aged

    Jose A Perez, Chief Information Officer, Hammondcare

    Digital Transformation - The Right Way

    Amit Goel, CIO, Metropolis Healthcare

    The (E-) Doctor Is In: What Trends to Spot in Healthcare Technology Today

    Dickon Smart-Gill, CIO, Bumrungrad International Hospital

    Analytics and AI in Healthcare

    Steven Parrish, CIO, Taranaki District Health Board

    Document Management in the Cloud

    Alex Choy, EVP R&D CIO, Change Healthcare

    China Embracing Connected Health

    Geoff Feakes, Group CIO, Tunstall Healthcare

    How Healthy is Your IT?

    John Sutherland-CIO-Ramsay Health Care

    Enterprise Architecture - An Extremely Valuable Discipline for Great Businesses

    Ken Spangler, SVP & CIO FedEx Ground and FedEx Freight, FedEx Services IT

    right

    Biocytogen Secures USD 142M in series D1 Round of Financing

    By Apac CIO Outlook | Monday, September 28, 2020
    Tweet

    In August, Beijing Biocytogen Biotechnology announced the acquisition of Eucure Biopharma, which established Biocytogen as a clinical-stage company.

    FREMONT, CA: Biocytogen, a Chinese clinical-stage company, raised $142 million in its series D1 funding. The round was led by CMB International, with participation from investor partners PICC Capital, SDIC Ventures, China Life Equity, 3E Bioventures, Cowin Capital, and Baifu Capital.

    Led by Chairman and CEO Dr.YueleiShen, Biocytogen is a global biotech company that drives the research and development of new drugs with innovative technologies. The company works jointly with international partners to accelerate new drug discovery and development.

    The company intends to use the funds to further secure the implementation of Project Integrum, a humanitarian effort to discover, develop, and bring to market novel therapeutic antibody candidates against all notoriously difficult druggable targets. Taking full advantage of Biocytogen’s integrated technology platforms for antibody discovery, Project Integrum will launch pre-clinical efforts into over 1,000 human diseases currently affecting countless lives.

    Whether it’s with RenMab-based target knockout mice, customized target humanized mouse models, in vivo pharmacology screening platforms, or even companion dog translational medicine, Biocytogen is determined to find antibodies with clinical translative value.

    tag

    Biotechnology

    Weekly Brief

    loading
    ON THE DECK

    Content Management System 2020

    Top Vendors

    Contactless Payments 2020

    Top Vendors

    Admired Tech 2020

    Top Vendors

    Previous Next

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Read Also

    How Credible is Cloud Storage Security?

    How Credible is Cloud Storage Security?

    How Internet of Medical Things Changing the Facets of Healthcare

    How Internet of Medical Things Changing the Facets of Healthcare

    IoT and the Challenges it Faces

    IoT and the Challenges it Faces

    Key Advantages of Cloud Computing

    Key Advantages of Cloud Computing

    Five Best Practices of Implementing ITSM

    Five Best Practices of Implementing ITSM

    Three Significant Benefits of Blockchain in Healthcare

    Three Significant Benefits of Blockchain in Healthcare

    Loading...

    Copyright © 2021 APAC CIOoutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy Policy  |  Sitemap |  Subscribe

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://www.apacciooutlook.com/news/biocytogen-secures-usd-142m-in-series-d1-round-of-financing-nwid-7750.html